首页> 美国卫生研究院文献>The Journal of Infectious Diseases >Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo
【2h】

Protection of Humanized Mice From Repeated Intravaginal HIV Challenge by Passive Immunization: A Model for Studying the Efficacy of Neutralizing Antibodies In Vivo

机译:通过被动免疫保护人源化小鼠免受重复性阴道内HIV挑战:研究体内中和抗体功效的模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Humanized mice reconstituted with a human immune system can be mucosally infected with human immunodeficiency virus (HIV), opening up the possibility of studying HIV transmission in a small-animal model. Here we report that passive immunization with the broadly neutralizing antibody b12 protected humanized mice against repetitive intravaginal infection in a dose-dependent manner. In addition, treatment with the antibody PGT126, which is more potent in vitro, was more efficacious in vivo and provided sterilizing protection. Our results demonstrate that humanized mice can be used as a small-animal model to study the efficacy and mechanism of broadly neutralizing antibody protection against HIV acquisition.
机译:重组有人类免疫系统的人源化小鼠可被粘膜感染人类免疫缺陷病毒(HIV),从而有可能在小动物模型中研究HIV传播。在这里我们报告说,用广泛中和的抗体b12进行的被动免疫以剂量依赖的方式保护了人源化小鼠免于重复性阴道内感染。另外,在体外更有效的抗体PGT126的治疗在体内更有效并且提供了灭菌保护。我们的结果表明,人源化的小鼠可以用作小动物模型,以研究广泛中和针对HIV感染的抗体保护的功效和机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号